Greinar 2000-2010

Pedersen RS, Brasch-Andersen C, Sim SC, Bergmann TK, Halling J, Petersen MS, Weihe P, Edvardsen H, Kristensen VN, Brøsen K, Ingelman-Sundberg M.
Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations. Eur J Clin Pharmacol. 2010 Dec;66(12):1199-205.

Ostergaard E, Batbayli M, Duno M, et al.
Mutations in PCDH21 cause autosomal recessive cone-rod dystrophy. J Med Genet 2010;47:665-9.

Joensen P.
Multiple sclerosis incidence in the Faroe Islands 1986-2007. Acta Neurol Scand. 2010 May;121(5):348-53. Epub 2009 Dec 15. PMID: 20015109

Hjortshoj TD, Gronskov K, Brondum-Nielsen K, Rosenberg T.
A novel founder BBS1 mutation explains a unique high prevalence of Bardet-Biedl syndrome in the Faroe Islands. Br J Ophthalmol 2009;93:409-13.

Morava E, Steuerwald U, Carrozzo R, Kluijtmans LA, Joensen F, Santer R, Dionisi-Vici C, Wevers RA.
Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion. 2009 Nov;9(6):438-42. Epub 2009 Aug 8.[]

Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grandjean P.
Prevalence and incidence of Parkinson’s disease in The Faroe Islands. Acta Neurol Scand. 2008 Aug;118(2):126-31. Epub 2008 Feb 19. PMID: 18294341

Halling J, Weihe P, Brosen K.
CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients. Ther Drug Monit. 2008 Jun;30(3):271-5.

Halling J, Petersen MS, Grandjean P, Weihe P, Brosen K.
Genetic predisposition to Parkinson's disease: CYP2D6 and HFE in the Faroe Islands. Pharmacogenet Genomics. 2008 Mar;18(3):209-12.

Halling J, Weihe P, Brosen K.
The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population. Br J Clin Pharmacol. 2008 Jan;65(1):134-8. Epub 2007 Aug 31.

Lund AM, Joensen F, Hougaard DM, Jensen LK, Christensen E, Christensen M et al.
Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit Metab Dis. 2007.

Carrozzo R, Dionisi-Vici C, Steuerwald U, Lucioli S, Deodato F, Di Giandomenico S, Bertini E, Franke B, Kluijtmans LA, Meschini MC, Rizzo C, Piemonte F, Rodenburg R, Santer R, Santorelli FM, van Rooij A, Vermunt-de Koning D, Morava E, Wevers RA.
SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.Brain. 2007 Mar;130(Pt 3):862-74. Epub 2007 Feb 14.

Ellefsen A, Kampmann H, Billstedt E, Gillberg IC, Gillberg C.
Autism in the Faroe Islands: an epidemiological study. J Autism Dev Disord. 2007;37:437-44.

Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL et al.
Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain. 2007;130:853-61.

Als TD, Jorgensen TH, Borglum AD, Petersen PA, Mors O, Wang AG.
Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands. Eur J Hum Genet. 2006;14:497-504.

Nolsøe RL, Bergholdt R, Deckert M, Róin J, Olsen SF, Kelly JA et al.
Identification of novel type 1 diabetes susceptibility loci in the Faroese population, a genetic isolate. Diabetologia. 2006;49 [Suppl 1]:177:0283.

Wang AG, Dahl HA, Vang M, Als TD, Ewald H, Kruse TA et al.
Genetics of panic disorder on the Faroe Islands: a replication study of chromosome 9 and panic disorder. Psychiatr Genet. 2006;16:99-104.

Halling J, Petersen MS, Damkier P, Nielsen F, Grandjean P, Weihe P, Lundgren S, Lundblad MS, Brøsen K.
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. Eur J Clin Pharmacol. 2005 Aug;61(7):491-7.

Joensen F, Steuerwald EU, Rasmussen NH.
Three congenital metabolic diseases in the Faeroe Islands. Incidence, clinical and molecular genetic characteristics of Faeroese children with glycogen storage disease type IIIA, carnitine transporter deficiency and holocarboxylase synthetase deficiency]. Ugeskr Laeger. 2006;168:667-70.

Fuchs J, Holm K, Vilhelmsen K, Rosenberg T, Scherfig E, Fledelius HC.
Hereditary high hypermetropia in the Faroe Islands. Ophthalmic Genet. 2005;26:9-15.

Als TD, Dahl HA, Flint TJ, Wang AG, Vang M, Mors O et al.

Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands. Mol Psychiatry. 2004;9:93-98.

Jeganathan D, Chodhari R, Meeks M, Faeroe O, Smyth D, Nielsen K et al.
Loci for primary ciliary dyskinesia map to chromosome 16p12.1-12.2 and 15q13.1-15.1 in Faroe Islands and Israeli Druze genetic isolates. J Med Genet. 2004;41:233-40.

Fledelius HC, Fuchs HJ, Rosenberg T.
Oculometric characteristics of extreme hypermetropia in two faroese families. Optom Vis Sci. 2004;81:762-68.

Jorgensen TH, Buttenschon HN, Wang AG, Als TD, Borglum AD, Ewald H.
The origin of the isolated population of the Faroe Islands investigated using Y chromosomal markers. Hum Genet. 2004;115:19-28.

Caldovic L, Morizono H, Panglao MG, Cheng SF, Packman S, Tuchman M.
Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia. Hum Genet. 2003;112:364-68.

Ewald H, Flint TJ, Jorgensen TH, Wang AG, Jensen P, Vang M et al.
Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am J Med Genet. 2002;114:196-204.

Jorgensen TH, Degn B, Wang AG, Vang M, Gurling H, Kalsi G et al.
Linkage disequilibrium and demographic history of the isolated population of the Faroe Islands. Eur J Hum Genet. 2002;10:381-87.

Jorgensen TH, Borglum AD, Mors O, Wang AG, Pinaud M, Flint TJ et al.
Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet. 2002;114:245-52.

Bille M, Munk-Nielsen L, Tranebjaerg L, Parving A.
Two families with phenotypically different hereditary low frequency hearing impairment: longitudinal data and linkage analysis. Scand Audiol. 2001;30:246-54.

Santer R, Kinner M, Steuerwald U, Kjaergaard S, Skovby F, Simonsen H et al.
Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur J Hum Genet. 2001;9:388-91.